[Leukotriene D4 antagonists].
Hamanaka
N
N
Minase Research Institute, ONO Pharmaceutical Co., Osaka, Japan.
Nakai
H
H
D016718:Arachidonic Acid / Q000378:metabolism; D002867:Chromones; D015195:Drug Design; D006801:Humans; D007211:Indoles; D020024:Leukotriene Antagonists; D015289:Leukotrienes / Q000096:biosynthesis / Q000502:physiology; D008565:Membrane Proteins; D048448:Phenylcarbamates; D018077:Receptors, Leukotriene / Q000502:physiology; D013189:SRS-A / Q000031:analogs & derivatives; D013449:Sulfonamides; D014105:Tosyl Compounds
C071435:BAY u9773; D002867:Chromones; D007211:Indoles; D020024:Leukotriene Antagonists; D015289:Leukotrienes; D008565:Membrane Proteins; D048448:Phenylcarbamates; D018077:Receptors, Leukotriene; D013189:SRS-A; D013449:Sulfonamides; D014105:Tosyl Compounds; D016718:Arachidonic Acid; C006312:FPL 55712; C412375:cysteinyl leukotriene receptor 2; C083169:leukotriene D4 receptor; C062735:zafirlukast